Verition Fund Management
GSK icon

Verition Fund Management’s GSK GSK Stock Holding History

Verition Fund Management’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.28M Sell
41,337
-8,031
-16% -$435K 0.01% 946
2025
Q4 		$2.42M Buy
+49,368
New +$2.3M 0.01% 1433
2025
Q3 		– Sell
-13,216
Closed -$516K – 3857
2025
Q2 		$507K Sell
13,216
-39,629
-75% -$1.51M ﹤0.01% 2933
2025
Q1 		$2.05M Buy
52,845
+44,930
+568% +$1.64M 0.01% 1557
2024
Q4 		$268K Sell
7,915
-9,177
-54% -$330K ﹤0.01% 2830
2024
Q3 		$699K Sell
17,092
-11,171
-40% -$457K ﹤0.01% 2110
2024
Q2 		$1.09M Buy
+28,263
New +$1.19M 0.01% 1622
2022
Q4 		– Sell
-55,959
Closed -$1.86M – 2379
2022
Q3 		$1.65M Buy
+55,959
New +$2.12M 0.02% 1046
2020
Q4 		– Sell
-4,546
Closed -$214K – 1209
2020
Q3 		$214K Buy
+4,546
New +$228K ﹤0.01% 916
2020
Q1 		– Sell
-398,711
Closed -$23.4M – 788
2019
Q4 		$23.4M Buy
398,711
+32,481
+9% +$1.81M 0.43% 47
2019
Q3 		$19.5M Buy
366,230
+921
+0.3% +$47.4K 0.54% 37
2019
Q2 		$18.3M Buy
365,309
+360,942
+8,265% +$18.1M 0.51% 35
2019
Q1 		$208K Buy
+4,367
New +$218K 0.01% 956
2018
Q3 		– Sell
-4,186
Closed -$211K – 1325
2018
Q2 		$211K Buy
+4,186
New +$211K 0.01% 983
2018
Q1 		– Sell
-13,597
Closed -$603K – 1195
2017
Q4 		$603K Buy
+13,597
New +$628K 0.06% 420
2017
Q3 		– Sell
-24,113
Closed -$1.3M – 1253
2017
Q2 		$1.3M Buy
+24,113
New +$1.29M 0.13% 138
2015
Q3 		– Sell
-3,889
Closed -$202K – 598
2015
Q2 		$202K Buy
+3,889
New +$219K 0.04% 477
2014
Q4 		– Sell
-4,464
Closed -$257K – 473
2014
Q3 		$257K Buy
+4,464
New +$274K 0.04% 465
2013
Q4 		– Sell
-4,323
Closed -$271K – 579
2013
Q3 		$271K Buy
4,323
+420
+11% +$27K 0.04% 363
2013
Q2 		$244K Buy
+3,903
New +$248K 0.04% 424

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Verition Fund Management's GSK Position: Q1 2026 in Review

Verition Fund Management reduced its GSK (GSK) stake by 16% in Q1 2026, selling an estimated $435K and leaving 41,337 shares worth $2.28M. The position accounts for 0.01% of the portfolio, ranked #946.

Verition Fund Management first reported a position in GSK in Q2 2013 and has held it in 20 quarters since. The position peaked at $23.4M in Q4 2019. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Verition Fund Management held 41,337 shares of GSK worth $2.28M as of Q1 2026.
  • Verition Fund Management sold 8,031 GSK shares in Q1 2026, an estimated $435K.
  • GSK made up 0.01% of Verition Fund Management's portfolio in Q1 2026, its #946 holding.
  • Verition Fund Management first reported a position in GSK in Q2 2013 and has held it in 20 quarters since.
  • Verition Fund Management's GSK position peaked at $23.4M in Q4 2019.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.